19522 Federal Register / Vol. 72, No. 74 / Wednesday, April 18, 2007 / Notices 

Dated: April 10, 2007. 

Elaine L. Baker, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. E7–7331 Filed 4–13–07; 10:39 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel ‘‘Health Promotion 

and Disease Prevention Research 

Centers: Special Interest Project 

Competitive Supplements (Panel 7),’’

Request for Application Number (RFA) 

DP07–002 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces a meeting of the 

aforementioned Special Emphasis 

Panel. 

Time and Date: 12 p.m.–4 p.m., June 5, 

2007 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the review, discussion, and 

evaluation of research grant applications 

received in response to RFA DP07–002, 

‘‘Health Promotion and Disease Prevention 

Research Centers: Special Interest Project 

Competitive Supplements (Panel 7).’’

Contact Person for More Information: 

Sheree Marshall Williams, PhD, M.Sc., 

Scientific Review Administrator, Centers for 

Disease Control and Prevention, 1600 Clifton 

Road, NE., MS D72, Atlanta, GA 30333, 

telephone 404.639.4896. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 

Dated: April 10, 2007. 

Elaine L. Baker 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. E7–7332 Filed 4–17–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Center for Injury Prevention 

and Control Initial Review Group 

(NCIPC/IRG) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meetings of the 

aforementioned committee: 

Times and Dates: 

2 p.m.–5 p.m., May 14, 2007 (Closed). 

2 p.m.–5 p.m., May 15, 2007 (Closed). 

2 p.m.–5 p.m., May 16, 2007 (Closed). 

2 p.m.–5 p.m., May 17, 2007 (Closed). 

2 p.m.–5 p.m., May 18, 2007 (Closed). 

Place: The conference calls will 

originate at the Centers for Disease 

Control and Prevention, Vanderbilt 

Building, Koger Center, Atlanta, 

Georgia. 

Times and Dates: 

9 a.m.–10 a.m., May 21, 2007 (Open). 

10 a.m.–5 p.m., May 21, 2007 

(Closed). 

9 a.m.–3 p.m., May 22, 2007 (Closed). 

3 p.m.–5 p.m., May 22, 2007 (Open). 

5 p.m.–7 p.m., May 22, 2007 (Closed). 

9 a.m.–5:30 p.m., May 23, 2007 

(Closed). 

9 a.m.–5 p.m., May 24, 2007 (Closed). 

Place: Sheraton Midtown Atlanta 

Hotel Colony Square, Atlanta, Georgia. 

Status: Portions of the meetings will 

be closed to the public in accordance 

with provisions set forth in Section 

552b(c)(4) and (6), Title 5, U.S.C., and 

the Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Section 10(d) 

of Public Law 92–463. 

Purpose: This group is charged with 

providing advice and guidance to the 

Secretary, Department of Health and 

Human Services, and the Director, CDC, 

concerning the scientific and technical 

merit of grant and cooperative 

agreement applications received from 

academic institutions and other public 

and private profit and nonprofit 

organizations, including State and local 

government agencies, to conduct 

specific injury research that focuses on 

prevention and control. 

Matters to be Discussed: The meeting 

will include the review, discussion, and 

evaluation of individual research grant 

and cooperative agreement applications 

submitted in response to two Fiscal 

Year 2007 Requests for Applications 

related to the following individual 

research announcements: 07002, Family 

and Dyadic Focused Interventions to 

Prevent Intimate Partner Violence; 

07003, Maximizing Protective Factors 

for Youth Violence; 07004, Abusive 

Head Trauma (AHT) Prevention; 07005, 

Understanding Bullying and Sexual 

Violence Perpetration and Factors 

Associated with Both Outcomes; 07006, 

Grants for Traumatic Injury 

Biomechanics Research; 07007, 

Dissemination Research on Fall 

Prevention: ‘‘Stepping On’’ in a U.S. 

Community Setting; and 07008, The 

Impact of Traumatic Brain Injury 

Among Incarcerated Persons. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Jane Suen, PhD, NCIPC/IRG, CDC, 4770 

Buford Highway, NE., M/S K02, Atlanta, 

Georgia 30341–3724, telephone 770/ 

488–1240. 

The Director, Management Analysis 

and Services Office has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities for both CDC and 

the Agency for Toxic Substances and 

Disease Registry. 

Dated: April 10, 2007. 

Elaine L. Baker, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. E7–7339 Filed 4–17–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Statement of Organization, Functions, 

and Delegations of Authority 

Part C (Centers for Disease Control 

and Prevention) of the Statement of 

Organization, Functions, and 

Delegations of Authority of the 

Department of Health and Human 

Services (45 FR 67772–76, dated 

October 14, 1080, and corrected at 45 FR 

69296, October 20, 1980, as amended 

most recently at 72 FR 14578, dated 

March 28, 2007) is amended to reflect 

the reorganization of the Coordinating 

Center for Infectious Diseases, Centers 

for Disease Control and Prevention. 

Section C–B, Organization and 

Functions, is hereby amended as 

follows: 

Delete in its entirety the mission 

statements for the Coordinating Center 

for Infectious Diseases (CV) and the 

Office of the Director (CVA), and insert 

the following: 


pwalker on PROD1PC71 with NOTICES
Federal Register / Vol. 72, No. 74 / Wednesday, April 18, 2007 / Notices 19523 

Coordinating Center for Infectious 

Diseases (CV). The mission of the 

Coordinating Center for Infectious 

Diseases (CCID) is to protect health and 

enhance the potential for full, satisfying, 

and productive living across the 

lifespan of all people in all communities 

related to infectious diseases. To carry 

out its mission, CCID: (1) Fosters 

collaborations across CID’s centers, 

divisions and branches, builds external 

and internal partnerships, supports both 

science and program integration, and 

leverages both human and budgetary 

resources to increase the Centers for 

Disease Control and Prevention’s (CDC) 

health impact and achieve population 

health goals; (2) helps investigate and 

diagnose infectious diseases of public 

health significance; (3) coordinates 

applied and operational research to 

define, prevent, and control infectious 

diseases; (4) assists in providing 

consultation and training to help state 

and local health departments plan, 

develop, implement, and improve 

immunization programs; (5) coordinates 

research and operational programs to 

prevent and control vaccine preventable 

diseases; and (6) assists in providing 

technical assistance to states, localities, 

and other nations to investigate and 

diagnose sexually transmitted diseases 

(STDs), viral hepatitis, tuberculosis 

(TB), human immunodeficiency virus 

(HIV) infections, and retroviruses; and 

coordinates applied and operational 

research on the spread, diagnosis, 

prevention, and control of HIV, other 

STDs, viral hepatitis, TB, and non-TB 

mycobacteria, and non-HIV retroviruses. 

Office of the Director (CVS). (1) 

Manages, coordinates, and evaluates the 

activities of the CCID; (2) communicates 

overarching goals and objectives, and 

provides leadership, scientific oversight, 

and guidance in program planning and 

development; (3) coordinates assistance 

provided by CCID to other CDC 

components, other federal, state, and 

local agencies, the private sector, and 

other nations; (4) provides and 

coordinates resource management 

support services for CCID; (5) manages 

and coordinates workforce development 

and succession planning activities 

within CCID in collaboration with 

internal and external partners, and 

coordinates the recruitment, 

assignment, technical supervision, and 

career development of staff with 

emphasis on developing and supporting 

diversity initiatives and equal 

opportunity goals; (6) assists in 

communication activities; (7) fosters 

collaboration of cross-cutting CCID 

scientific and programmatic issues 

through the Strategic Science and 

Program Unit; and (8) ensures 

consistent, efficient, and effective 

administration of mission support 

functions through the establishment and 

management of the Strategic Business 

Unit. 

Strategic Business Unit (CVA2). The 

mission of the Strategic Business Unit 

(SBU) is to support CCID programs and 

staff through the efficient, professional, 

and timely delivery of critical public 

health mission-support services. In 

carrying out its mission, the SBU 

performs the following functions: (1) 

Provides direct and daily management 

and execution of domestic travel 

processing for federal employees, 

Commissioned Corps, and all CDCinvited guests; (2) provides direct and 

daily management and execution of the 

administrative aspects of human 

resources across CCID, including 

training and administration of policies 

and guidelines developed by the Atlanta 

Human Resources Center, Department of 

Health and Human Services (HHS), 

Ethics Office, Financial Management 

Office (FMO), Office of Commissioned 

Corps Personnel, Coordinating Office for 

Global Health (COGH), Office of 

Personnel Management, Office of 

Workforce and Career Development, and 

Procurement and Grants Office (PGO); 

(3) provides direct and daily 

management and execution of the 

coordination of laboratory and office 

facilities, and supplies technical 

guidance and expertise regarding 

occupancy and facilities management to 

emergency situations, CDC; (4) provides 

direct and daily management and 

execution of the distribution, 

accountability, and maintenance of CDC 

property and equipment; (5) provides 

direct and daily management and 

execution of the creation, organization, 

access, maintenance, and disposition of 

CCID records, and of the establishment 

of policies and procedures coordinating 

a CCID response to Freedom of 

Information Act (FOIA) requests; and (6) 

provides direct and daily management 

and execution of the coordination of 

logistics for CCID’s federal government 

committee meetings and conferences. 

Travel (CVA22). (1) Prepares for 

approval travel requests, travel orders, 

vouchers for reimbursement, in-kind, 

reimbursable, relocation services, and 

permissive travel documentation for 

domestic travel; (2) administers and 

provides oversight for travel cards; 

follows up with audits; communicates 

with national centers (NC) regarding 

possible fraud, delinquencies, and 

abuses; troubleshoots for lost or stolen 

cards; and, generates related reports; (3) 

provides emergency travel support in 

response to emergencies, outbreaks, and 

domestic incidents; (4) prepares group 

travel memos to HHS for meetings in 

excess of 20 attendees (meetings), 

conferences in excess of 99 attendees, 

actual expense memos, premium class 

(medical) memos, and cash purchase 

memos; and (5) provides guidance and 

expertise pertaining to travel. 

Personnel/Training (CVA23). (1) 

Processes security clearance forms, ID 

badges, and card keys for FTEs and nonFTEs; (2) performs administrative 

aspects of recruitment, retention and 

promotion; (3) manages administrative 

functions related to employee 

performance (EPMS, ceremonies, 

awards, promotions); (4) manages 

administrative functions related to 

Commissioned Corps; (5) serves as point 

of contact for payroll issues including 

time/attendance records, executive pay 

appointments, bonuses/allowances, and 

other special pay agreements; (6) 

manages administrative functions for 

non-CDC employees including ORISE 

fellows, Student Temporary 

Employment Program, contractors, guest 

researchers, and interagency agreements 

(IAA); (7) performs administrative 

functions related to staffing and other 

human resource issues including 

employee relations, FTE tracking, onboard strength reports, PeopleSoft 

Access, WIZ data and staffing lists, 

individual development plans (IDP), 

and individual learning accounts (ILA); 

manages IDP/ILA accounts and tracks 

completion of IDPs; (8) enters training 

requests into mainframe and forwards 

requests to appropriate channels for 

approval; (9) verifies requested training 

is on IDP; (10) tracks scheduling and 

completion of CDC-required training 

courses; (11) maintains accurate training 

log in mainframe; (12) tracks and prints 

certifications for staff that have 

completed training courses; (13) 

manages vendor registration process and 

initiates payment process for vendors 

who provide training; and (14) assists 

with scheduling CCID employees for 

Corporate University courses. 

Procurement/Property/Facilities 

(CVA24). (1) Processes purchase orders, 

requisitions, and contracts using ICE; (2) 

processes credit card transactions for 

purchases <$2,500 using MACCS; (3) 

manages receiving and acceptance for 

both ICE and Visa orders; (4) serves as 

liaison with CCID lead to respond to ICE 

inquiries; (5) performs administrative 

tasks related to initiating, processing, 

and maintaining IAA; (6) processes 

contract invoices and payments; (7) 

reviews and approves all issues and 

requests related to office and laboratory 

space; (8) serves as liaison with 

programs and other necessary parties 

(Buildings and Facilities Office, Office 


pwalker on PROD1PC71 with NOTICES
19524 Federal Register / Vol. 72, No. 74 / Wednesday, April 18, 2007 / Notices 

of Health and Safety (OHS), Office of 

Security and Emergency Response 

(OSEP), Real Properties Office, etc.) to 

oversee the implementation of all 

approved requests; (9) coordinates 

funding for facilities projects; (10) works 

closely with OSEP and Physical 

Security to coordinate, approve, and 

monitor access to restricted high 

security laboratory buildings and select 

agent laboratories; (11) serves as liaison 

with architects and engineers regarding 

construction projects; (12) provides 

scientific and technical guidance, and 

coordination of resources during 

emergency operations; (13) serves on 

CDC Emergency Response Team 

subcommittee; (14) accounts for CDC 

property (computers, laptops, cell 

phones, Blackberries, etc.) and 

laboratory equipment; (15) tracks 

repairs, losses, and maintenance 

agreements; (16) facilitates acquisition 

replacement parts; (17) serves as liaison 

to the Information Technology Services 

Office for technical approval of 

information technology (IT) related 

purchases; (18) coordinates with 

appropriate parties to access and 

distribute property and equipment; (19) 

coordinates annual inventory process; 

and (20) purchases, maintains, and 

checks-out/-in barcode scanners for use 

by programs for annual inventory. 

Records Management/FOIA/ 

Committee/Management/Conference 

Logistics (CVA25). (1) Responsible for 

physical transfer of files to Federal 

Records Center (pack boxes, record 

contents, transfer boxes to courier); (2) 

organizes and classifies files throughout 

the organization; (3) maintains and 

staffs file stations throughout the 

organization; (4) assists the CDC 

Records Officer in the development of 

records management schedules; (5) 

receives and interprets requests directly 

from CDC FOIA office; (6) checks for 

similar and/or duplicate requests; (7) 

performs preliminary work (scanning, 

copying); (8) creates and maintains files 

in the FOIA log; (9) disburses requests 

to center/division/programs (CDP); (10) 

sends time-sensitive reminders to CDP 

liaisons and others working on request; 

(11) receives completed responses from 

programs; (12) evaluates information 

and works with the CDC FOIA Office 

and program coordinators to ensure that 

all response packages are complete and 

within the scope of the request; (13) 

performs secondary review for 

identifying possibly exempt material; 

(14) serves as liaison with CDC FOIA 

Office and CDC Office of General 

Counsel for complex requests; (15) 

sends all responses to CDC FOIA Office 

for final review; (16) works with records 

management group to develop and 

adhere to a uniform record retention 

policy regarding FOIA requests; (17) 

conducts training for scientists and 

program staff on FOIA exemptions and 

response process; (18) initiates all 

personnel actions for CCID committee 

members; (19) coordinates meeting 

logistics, travel arrangements, 

production and distribution of 

materials, and preparation and 

distribution of meeting transcripts; (20) 

maintains agendas, minutes, records, 

reports and transcripts; (21) records 

action items and provides feedback to 

the committees via written and 

electronic correspondence; (22) prepares 

standardized committee reports for 

Government Services Agency, HHS, and 

the Management Analysis and Services 

Office (MASO); (23) finalizes nominee 

packages for CCID committees; (24) 

coordinates contractor support; (25) 

prepares and assembles technical 

proposal packages; (26) coordinates 

administrative requirements to ensure 

abstract review/approval by appropriate 

program and scientific staff; (27) 

processes conference facility and 

support contracts; (28) finalizes 

memorandums of understanding, obtain 

legal clearance as needed, and 

maintains records; (29) supports 

conference registration procedures as 

needed; (30) coordinates 

communications to committee members, 

speakers, and attendees as directed by 

programmatic personnel; (31) processes 

orders and payments of print and nonprint conference materials; (32) 

assembles conference materials; (33) 

coordinates follow-up with invited 

participants; (34) coordinates ordering 

and shipment of conference supplies to 

be used on-site; and (35) coordinates onsite conference administrative staffing 

support. 

Strategic Science and Program Unit 

(CVA3). The mission of the Strategic 

Science and Program Unit (SSPU) is to 

provide scientific and laboratory 

services to stakeholders across CCID. In 

carrying out its mission, the SSPU: (1) 

Ensures process consistency for science 

and laboratory related functions across 

the NCs; (2) facilitates cross-center 

decision-making regarding science and 

laboratory activities; (3) facilitates 

communication regarding scientific and 

programmatic services across CCID; (4) 

develops and administers, in 

collaboration with CCID’s divisions/ 

programs/offices, requests for 

applications and program 

announcements for extramural research; 

(5) serves as the focal point for 

implementing policies and guidelines 

for the conduct of the peer review of 

extramural research grant proposals and 

subsequent grant administration; (6) 

monitors the performance of funded 

extramural research projects in the areas 

of infectious diseases and 

immunization; (7) conducts necessary 

regulatory and ethical reviews for 

activities involving human participants, 

including determining whether an 

activity includes research, includes 

human subjects, is exempt or requires 

Institutional Review Board (IRB) 

approval, and whether an exception is 

needed to the Public Health Service 

(PHS) HIV policy; (8) reviews funded 

activities for application of human 

research regulations; completes PGO 

tracking forms for Funding Opportunity 

Announcements and contracts; (9) 

reviews, approves, and tracks research 

protocols, clinical investigations, and 

the Food and Drug Administration 

(FDA) regulated response activities 

intended for submission to CDC Human 

Research Protections Office; (10) 

coordinates and tracks Office of 

Management and Budget (OMB) 

clearance under the Paperwork 

Reduction Act; (11) serves as authorized 

representative to/from FDA on all CDC 

Investigational New Drug (IND) 

protocols, Investigational Device 

Exemption applications, 510(k) 

applications, pre-Emergency Use 

Authorization (EUA) requests, and Drug 

Master File submissions; (12) centralizes 

and standardizes all CDC/FDA official 

correspondences; (13) drafts, reviews, 

prepares, and tracks all IND Protocols 

regulated by 21 CFR 312 and all preEUA documents; (14) develops and 

maintains standard operating 

procedures (SOP) and templates for 

processing non-research actions through 

the NCs to PGO; (15) monitors changes 

in grants management policies and 

procedures and adjusts SOPs as 

necessary; (16) liaises with PGO 

regarding general policies, procedures 

and forecasting; (17) organizes and 

coordinates logistics for panel reviews 

for non-research programs; (18) receives 

and reviews research proposals and 

initiates contact with technology 

transfer specialist; (19) negotiates terms 

of agreements with external parties; (20) 

reviews patent/intellectual property 

issues and potential conflicts of interest; 

(21) liaises with CCID organizations to 

advise, plan, coordinate, implement, 

manage, and oversee the allocation of 

additional or alternate laboratory, 

laboratory support, and laboratory office 

space; (22) plans and advises relocation 

into existing buildings and newly 

acquired laboratory, lab office, and lab 

support space; (23) serves as advisor to 

CCID management on issues of safety, 


pwalker on PROD1PC71 with NOTICES
Federal Register / Vol. 72, No. 74 / Wednesday, April 18, 2007 / Notices 19525 

including biosafety, chemical safety, 

and radiation safety; (24) serves as the 

principal liaison to the OHS; (25) 

coordinates CCID safety program, 

working with all levels of CCID safety 

committees; and (26) monitors safety 

survey process and findings and ensures 

that all deficiencies are addressed in 

timely manner (remediation). 

Informatics (CVA33). The mission of 

the CCID Informatics is to maximize the 

capacity for information technology to 

enhance the efficacy of infectious 

disease prevention. In carrying out its 

mission, Informatics: (1) Manages all IT 

project costs, schedules, performances, 

and risks; (2) provides expertise in 

leading application development 

techniques in information science and 

technology to effect the best use of 

resources; (3) performs technical 

evaluation and/or integrated baseline 

reviews of all information systems’

products and services prior to 

procurement to ensure software 

purchases align with CCID strategy; (4) 

provides access to quality data in 

support of programmatic data analysis; 

(5) coordinates all enterprise-wide IT 

security policies and procedures with 

the office of the CDC Chief Information 

Security Officer; (6) ensures operations 

are in accordance with CDC Capital 

Planning and Investment Control 

guidelines; (7) ensures adherence to 

CDC enterprise architecture guidelines 

and standards; (8) consults with users to 

determine IT needs and to develop 

strategic and action plans; and (9) 

participates in the evolution, 

identification, development, or adoption 

of appropriate informatics standards in 

conjunction with the Coordinating 

Center for Health Information and 

Service. 

Enterprise Communications (CVA32). 

The mission of the CCID Enterprise 

Communications (EC) is to lead CCID’s 

support of the CDC Office of Enterprise 

Communication (OEC) in promoting 

public health and preventing disease 

through coordination and prompt 

response to urgent issues and concerns; 

recognition of issues requiring 

establishment or reevaluation of agency 

positions; safeguarding CCID and CDC 

credibility with, and confidence of, 

employees, partners and public; 

promotion and maintenance of effective 

and efficient communication networks. 

In carrying out its mission, CCID EC: (1) 

Organizes, develops, and implements 

employee communication activities; 

develops, writes, edits, and publishes 

articles about CCID employees and their 

work through a variety of channels; (2) 

provides channels for publicizing 

employee achievements and awards, 

program accomplishments, and 

introducing new staff and management; 

(3) provides the central point of contact 

to CCID for the CCID Intranet; (4) 

provides a central point of reference for 

CCID announcements; (5) coordinates 

review and clearance of materials to be 

posted on CCID Intranet; (6) provides 

leadership in the development and 

branding of CCID’s Intranet sites/pages; 

(7) assists the CCID and NC leadership 

in meeting their employee 

communication needs and priorities; (8) 

creates and maintains liaison with the 

CDC OEC, CDC Connects, and CCID NCs 

to share relevant employee 

communications information; (9) 

provides opportunities for two-way 

CCID employee communication, and 

timely and appropriate responses to 

inquiries and feedback from CCID 

employees; (10) conducts special 

projects as appropriate to develop 

feature CCID employee stories; (11) 

conducts employee research to enhance 

and improve CCID employee 

communication efforts including the 

CCID Intranet and other channels of 

employee communication; (12) provides 

employees access to information, 

services, activities, and materials that 

support or promote their health, morale, 

work efficiency, and sense of 

community; (13) serves as point of 

contact for controlled correspondence 

and other documents that require 

approval from the CCID Director and 

various other officials; (14) manages the 

flow of decision documents and 

correspondence for action by the CCID 

and NC directors; (15) coordinates 

collection and electronic management of 

CCID NC issues management materials; 

(16) ensures consistent application of 

CDC correspondence standards and 

styles; (17) coordinates CCID very 

important persons (VIP) visits and CCID 

lab tours for VIP visitors; (18) 

coordinates compilation of regularly 

updated CCID NC reports containing 

information on upcoming publications, 

activities, and other issues related to 

potential media opportunities, and 

CDC/ATSDR weekly legislative report 

for dissemination to CCID executive 

leadership team, CDC OEC, 

Coordinating Centers/Coordinating 

Offices (CC/CO), and NCs; (19) 

coordinates collection and electronic 

management of CCID and CCID NC 

issues management materials to include 

talking points, position papers, and 

others; (20) assists CCID NCs in meeting 

their press-related needs and priorities 

and provides or coordinates media 

training and technical assistance to 

CCID staff; (21) provides a central point 

of contact to CDC Division of Media 

Relations for CCID related media 

requests and manages electronic files; 

and (22) provides a central point for 

CCID media monitoring. 

National Center for Immunization 

and Respiratory Diseases (CVG). The 

National Center for Immunization and 

Respiratory Diseases (NCIRD) prevents 

disease, disability, and death through 

immunization and by control of 

respiratory and related diseases. In 

carrying outs its mission, NCIRD: (1) 

Provides leadership, expertise, and 

service in laboratory and 

epidemiological sciences, and in 

immunization program delivery; (2) 

conducts applied research on disease 

prevention and control; (3) translates 

research findings into public health 

policies and practices; (4) provides 

diagnostic and reference laboratory 

services to relevant partners; (5) 

conducts surveillance and research to 

determine disease distribution, 

determinants, and burden nationally 

and internationally; (6) responds to 

disease outbreaks domestically and 

abroad; (7) ensures that public health 

decisions are made objectively and 

based upon the highest quality of 

scientific data; (8) provides technical 

expertise, education, and training to 

domestic and international partners; (9) 

provides leadership to internal and 

external partners for establishing and 

maintaining immunization, and other 

prevention and control programs; (10) 

develops, implements, and evaluates 

domestic and international public 

health policies; (11) communicates 

information to increase awareness, 

knowledge, and understanding of public 

health issues domestically and 

internationally, and to promote effective 

immunization programs; (12) aligns the 

national center focus with the overall 

strategic goals of CDC; and (13) 

implements, coordinates, and evaluates 

programs across NCIRD, CCID, and CDC 

to optimize public health impact. 

Office of the Director (CVG). (1) 

Provides leadership, expertise, and 

service in laboratory and 

epidemiological sciences and in 

immunization program delivery; (2) 

provides diagnostic and reference 

laboratory services to relevant 

partnerships; (3) works with CCID OD to 

ensure spending plans, budget planning, 

and budget execution are in line with 

the overall infectious disease strategies 

and priorities; (4) ensures that the CCID 

strategy is executed by the divisions and 

aligned with overall CDC goals; (5) codevelops execution strategies for the 

center with the division directors; (6) 

provides program and science quality 

oversight; (7) builds leadership at the 

division and branch levels; (8) evaluates 

the strategies, focus, and prioritization 


pwalker on PROD1PC71 with NOTICES
19526 Federal Register / Vol. 72, No. 74 / Wednesday, April 18, 2007 / Notices 

of the division research, program, and 

budget activities; (9) identifies and 

coordinates synergies between center 

and relevant partners; (10) ensures that 

policy development is consistent and 

appropriate; (11) facilitates research and 

program activities by providing 

leadership support; (12) proposes 

resource priorities throughout the 

budget cycle; (13) ensures scientific 

quality, ethics, and regulatory 

compliance; (14) fosters an integrated 

approach to research, program, and 

policy activities; (15) liaises with HHS 

and other domestic and international 

immunization and respiratory disease 

partners as well as with NCIRD 

divisions; and (16) coordinates center’s 

emergency response activities related to 

immunization issues and complex acute 

respiratory infectious disease 

emergencies. 

National Center for Zoonotic, VectorBorne, and Enteric Diseases (CVH). The 

National Center for Zoonotic, VectorBorne, and Enteric Diseases (NCZVED) 

maximizes public health and safety 

nationally and internationally through 

the elimination, prevention, and control 

of disease, disability, and death caused 

by suspected and confirmed zoonotic, 

vector-borne, foodborne, waterborne, 

mycotic, prion, and related infections. 

In carrying out its mission, NCZVED: (1) 

Provides leadership, expertise, and 

service in laboratory, medical, and 

epidemiological sciences throughout the 

world; (2) conducts applied research 

aimed to eliminate, prevent, and control 

disease; (3) translates research findings 

into public health policies, practices, 

and programs; (4) provides diagnostic 

and reference laboratory services to 

relevant partners; (5) conducts 

surveillance and research to determine 

disease distribution, disease 

determinants, and disease burden 

nationally and internationally; (6) 

responds to disease outbreaks 

domestically and abroad; (7) ensures 

that public health decisions are made 

objectively and based upon the highest 

quality of scientific data; (8) provides 

technical expertise, education, and 

training to domestic and international 

partners; (9) provides leadership to 

internal and external partners for 

establishing and maintaining screening, 

treatment, and other elimination, 

prevention, and control programs; (10) 

develops, implements, and evaluates 

domestic and international public 

health policies, practices, and programs; 

(11) communicates information to 

increase awareness, knowledge, and 

understanding of public health issues 

domestically and internationally; (12) 

aligns the national center focus with the 

overall strategic goals of the CDC; (13) 

implements, coordinates, and evaluates 

programs across CDC, CCID, and 

NCZVED to optimize public health 

impact; (14) conducts bioterrorism 

preparedness activities to prevent or 

lessen the severity of bioterrorism 

incidents; (15) builds strategic 

partnerships with internal and external 

stakeholders; and (16) clarifies the 

dynamic link between animals, people, 

and the environment to maximize 

public health impact. 

Office of the Director (CVH1). (1) 

Works with CCID OD to ensure 

spending plans, budget planning, and 

budget execution are in line with the 

overall CDC infectious disease strategies 

and priorities; (2) ensures that the CCID 

strategy is executed by the divisions and 

aligned with overall CDC goals; (3) codevelops execution strategies for the 

national center with the division 

directors; (4) provides program and 

science quality oversight; (5) builds 

leadership at the division and branch 

levels; (6) evaluates the strategies, focus, 

and prioritization of the division 

research, program, and budget activities; 

(7) identifies and coordinates synergies 

between the national center and 

relevant partners; (8) ensures that policy 

development is consistent and 

appropriate; (9) facilitates research and 

program activities by providing 

leadership support; (10) proposes 

resource priorities throughout the 

budget cycle; (11) ensures scientific 

quality, ethics, and regulatory 

compliance; (12) fosters an integrated 

approach to research, program, and 

policy activities; (13) liaises with HHS 

and partners concerning activities 

related to vector-borne, zoonotic, and 

enteric infectious diseases; and (14) 

ensures that programmatic goals are 

achieved with measurable impact. 

National Center for HIV/AIDS, Viral 

Hepatitis, STD, and TB Prevention 

(CVJ). The National Center for HIV/ 

AIDS, Viral Hepatitis, STD, and TB 

Prevention (NCHHSTP) maximizes 

public health and safety nationally and 

internationally through the elimination, 

prevention, and control of disease, 

disability, and death caused by Human 

Immunodeficiency Virus Infection/ 

Acquired Immunodeficiency Syndrome 

(HIV/AIDS), non-HIV retroviruses, viral 

hepatitis, other STDs, TB, and nontuberculosis mycobacteria. In carrying 

out its mission, NCHHSTP: (1) Builds 

capacity and enhances public health 

infrastructure for preventing and 

treating HIV/AIDS, viral hepatitis, STDs, 

and TB domestically and 

internationally; (2) coordinates activities 

and programs across CDC and CCID in 

order to maximize the public health 

impact of HIV/AIDS, viral hepatitis, 

STDs, and TB interventions; (3) 

conducts surveillance and research to 

determine the distribution, 

determinants, and burden of HIV/AIDS, 

viral hepatitis, STDs, and TB infections 

domestically and internationally; (4) 

conducts program evaluation to improve 

programs and activities relating to the 

prevention of HIV/AIDS, viral hepatitis, 

STDs, and TB, and determine their 

impact; (5) provides reference laboratory 

and clinical diagnostic services for HIV/ 

AIDS, viral hepatitis, STDs, and TB to 

relevant stakeholders; (6) maximizes 

synergies among HIV/AIDS, viral 

hepatitis, STDs, and TB programs; 

domestically and internationally; (7) 

engages external partners to develop 

and implement effective HIV/AIDS, 

viral hepatitis, STDs, and TB policies, 

research, and programs; (8) engages 

partners to reduce health disparities 

among those affected by HIV/AIDS, viral 

hepatitis, STDs, and TB; (9) provides 

technical assistance and training to 

domestic and international partners in 

the diagnosis, treatment, and prevention 

of HIV/AIDS, viral hepatitis, STDs, and 

TB; (10) conducts domestic and 

international public health 

communication activities to disseminate 

research findings and increase 

awareness of HIV/AIDS, viral hepatitis, 

STDs, and TB; (11) conducts 

operational, behavioral, and biomedical 

research to improve the distribution, 

diagnosis, prevention, and control of 

HIV/AIDS, viral hepatitis, STDs, and 

TB; (12) provides scientific leadership 

regarding public health ethics and 

protection of human subjects linked to 

HIV/AIDS, viral hepatitis, STDs, and 

TB; (13) translates research findings into 

public health practice and policy for 

HIV/AIDS, viral hepatitis, STDs, and 

TB; (14) plans, coordinates, and guides 

programs and activities with external 

partners, federal agencies, and other 

organizations related to HIV/AIDS, viral 

hepatitis, STDs, and TB prevention, 

care, and treatment; (15) leads and 

participates in the development, 

implementation, and evaluation of 

domestic and international policies and 

guidelines related to HIV/AIDS, viral 

hepatitis, STDs, and TB; (16) provides 

scientific leadership regarding 

screening, treatment, immunization, and 

other prevention interventions relevant 

to HIV/AIDS, viral hepatitis, STDs, and 

TB; (17) assures all public health 

decisions are based on the highest 

quality scientific data, openly and 

objectively derived; (18) provides 

leadership to assist international 

partners in establishing and maintaining 

HIV/AIDS, viral hepatitis, STDs, and TB 


pwalker on PROD1PC71 with NOTICES
Federal Register / Vol. 72, No. 74 / Wednesday, April 18, 2007 / Notices 19527 

screening, treatment, immunization, and 

other prevention and control programs; 

(19) assists countries in improving 

treatment, care, and support for people 

living with HIV/AIDS, and building 

capacity and infrastructure to address 

the global HIV/AIDS pandemic; (20) 

works with other federal agencies, 

governments of other nations, and other 

partners to implement the U.S. 

Government’s international efforts to 

reduce the global burden of HIV/AIDS; 

(21) ensures that programmatic and 

scientific activities are aligned with, and 

in support of, CDC’s overall mission, 

goals, and strategic imperatives; (22) 

allocates and tracks CDC resources and 

contributes to the development of CDC’s 

short-, medium- and long-term strategic 

plans for preventing the spread of HIV/ 

AIDS, viral hepatitis, STDs, and TB 

domestically and internationally; and 

(23) coordinates oversight of the 

NCHHSTP Federal Advisory 

Committees. 

Office of the Director (CVJ1). (1) 

Provides leadership and guidance on 

the development of goals and objectives, 

policies, program planning and 

development, and program management 

and operations of the activities of the 

NCHHSTP, and manages, directs, 

coordinates, and evaluates the center’s 

activities; (2) facilitates closer linkages 

between HIV, non-HIV retroviruses, 

STDs, viral hepatitis, TB, and non-TB 

mycobacteria surveillance activities and 

prevention programs at all levels, and 

facilitates collaboration, integration, and 

multi-disciplinary approaches to 

enhance the effectiveness of HIV, STD, 

viral hepatitis, and TB prevention 

programs; (3) facilitates integration of 

science and prevention programs 

throughout NCHHSTP and enhances the 

coordination and integration of HIV, 

STD, viral hepatitis, and TB prevention 

services for individuals and populations 

at increased risk for more than one of 

these infections; (4) coordinates the 

integration of CDC funding of state and 

local health departments for HIV, STD, 

viral hepatitis, and TB prevention; (5) 

facilitates and coordinates the 

assignment of field staff in accordance 

with CDC and NCHHSTP priorities and 

objectives; (6) provides technical 

information services to facilitate 

dissemination of relevant public health 

information and facilitates collaboration 

with national health activities, CDC 

components, other agencies and 

organizations, and foreign governments 

on international health activities; (7) 

provides oversight for the programmatic 

coordination of HIV, STD, viral 

hepatitis, and TB activities between 

NCHHSTP and other NCs; develops 

recommendations to the CDC Director as 

the lead NC for these programs for the 

distribution of HIV, STD, viral hepatitis, 

and TB funds CDC-wide; and advises 

the Director, CDC, on other policy 

matters concerning NCHHSTP activities; 

(8) provides technical assistance to 

divisions on issues management, public 

affairs, and health communications 

strategies, and coordinates with external 

organizations, the news, public service, 

entertainment and other media to 

ensure effective findings and their 

implications for public health reach the 

public; (9) collaborates closely with 

divisions to produce materials designed 

for use by the news media; (10) secures 

appropriate clearance of these materials 

within NCHHSTP and CDC; (11) 

develops strategies and operational 

systems for the proactive dissemination 

of effective findings and their 

implications for prevention partners and 

the public, responds to public inquiries, 

and distributes information materials 

apart from the clearinghouses, hotlines, 

or other contractual mechanisms; (12) 

coordinates graphics and publishing 

services for NCHHSTP staff; reviews 

and prepares congressional testimony 

and briefing documents; and analyzes 

the implications of legislation and 

legislative proposals; (13) plans and 

coordinates the annual program 

planning process; (14) coordinates with 

OD, CC/COs, and divisions in 

determining and interpreting operating 

policy and in ensuring their respective 

management input for specific program 

activity plans; (15) interprets general 

policy directives and proposed 

legislation relating to NCHHSTP 

program goals and objectives, and 

coordinates the development and 

review of congressional reports; serves 

as the coordination point for Inspector 

General and General Accounting Office 

audits and reviews; (16) coordinates and 

manages external groups such as 

advisory committees and serves as 

central point for OMB clearances and 

controlled correspondence; (17) advises 

on activities that might affect other NC 

and provides leadership in the 

integration of health disparities goals, 

objectives, and strategies in the 

development of policies and programs 

of NCHHSTP; (18) coordinates and 

tracks health disparity activities within 

the center and provides leadership in 

support of research, surveillance, 

education, training, and program 

development to reduce health 

disparities; (19) develops partnerships 

with other federal agencies and 

nongovernmental organizations working 

on similarly-affected populations; (20) 

provides technical support and funding 

to the Tuskegee University National 

Center for Bioethics in Research and 

Health Care and manages the Tuskegee 

Participants Health Benefits Program; 

(21) sponsors workgroups, meetings, 

and conferences related to health 

disparities and collaborates with the 

CDC Office of the Director, CC/COs, and 

other NCs on health disparity activities; 

(22) works with NCHHSTP leadership to 

promote a diverse public health 

workforce through internships, 

fellowships, training programs, and 

other activities; and (23) works with the 

CDC Office of Minority Health and 

Health Disparities to monitor progress 

in meeting the four Executive Orders 

related to improving minority health. 

National Center for Preparedness, 

Detection, and Control of Infectious 

Diseases (CVK). The National Center for 

Preparedness, Detection, and Control of 

Infectious Diseases (NCPDCID) 

maximizes prevention, preparedness, 

and response to infectious diseases in 

order to protect populations 

domestically and internationally 

through leadership, partnerships, 

epidemiologic and laboratory studies, 

and the use of quality systems, 

standards, and practices. In carrying out 

its mission, NCPDCID: (1) Works 

collaboratively across CDC and with 

public health and healthcare partners in 

conducting, coordinating, and 

supporting surveillance, research, and 

prevention programs to prevent and 

minimize morbidity and mortality 

among domestic and international 

populations; (2) collaborates with other 

CDC programs to ensure availability of 

appropriate domestic and international 

platforms intended to build capacity 

and conduct public health work on 

infectious diseases; (3) coordinates 

activities across CCID and CDC related 

to vulnerable populations, healthcare 

quality, quarantine, research, 

surveillance, emerging infectious 

diseases, and laboratory services; (4) 

establishes relationships and 

partnerships with domestic and 

international health organizations, 

healthcare facilities, federal agencies, 

state and local health departments, and 

other external partners; (5) provides 

technical assistance to external 

partnerships for improving program 

operations; (6) provides a platform for 

synthesis, translation, and 

dissemination of research findings into 

public health practice at the front line; 

(7) participates in the development of 

national policies and guidelines for 

prevention and control of infectious 

diseases; (8) coordinates processes for 

developing, awarding, and managing 

grants and cooperative agreements; (9) 


pwalker on PROD1PC71 with NOTICES
19528 Federal Register / Vol. 72, No. 74 / Wednesday, April 18, 2007 / Notices 

administers a national quarantine 

program to protect the U.S. against the 

introduction of diseases from foreign 

countries and the transmission of 

communicable disease between states; 

(10) facilitates appropriate cross-cutting 

collaboration with other NCs, CCID, 

other CDC programs, and external 

partners to promote effective 

surveillance for infectious threats to 

health; (11) designs and conducts 

epidemiologic studies to investigate the 

causes and risk factors for infectious 

diseases; (12) identifies, evaluates, and 

promotes the nationwide 

implementation of interventions 

designed to prevent infectious diseases, 

antimicrobial resistance, related adverse 

events, and medical errors among 

patients and healthcare personnel; (13) 

investigates and responds to outbreaks, 

emerging infections, and related adverse 

events among patients, healthcare 

providers, and others associated with 

the healthcare environment; (14) leads 

the improvement of domestic and 

international laboratory practices in 

clinical and public health laboratories 

through a quality systems approach; (15) 

provides services and expertise in 

development of quality systems to 

support compliance with FDA 

regulations on production, distribution, 

and use of laboratory diagnostic 

reagents; (16) provides support to CDC 

laboratories and investigators including 

provisions of animals, services, 

materials, and specialized expertise; and 

(17) provides emergency response 

coordination to CCID resources and 

enhanced epidemiologic, surveillance, 

and laboratory response capacity for 

bioterrorism and other infectious 

disease public health emergencies. 

Office of the Director (CVK1). (1) 

Directs and manages the science, 

programs and activities of the NCPDCID; 

(2) provides leadership and 

coordination for the development and 

implementation of programs to enhance 

the prevention and control of infectious 

diseases nationally and internationally; 

(3) provides leadership and guidance on 

policy, program planning and 

development, program integration, 

management, and operations; (4) 

identifies and coordinates synergies 

between national centers and relevant 

partners; (5) provides technical 

information services to facilitate 

dissemination of relevant public health 

information; (6) provides liaison with 

other Governmental agencies and 

international organizations; (7) 

coordinates, in collaboration with the 

appropriate CCD and CDC components, 

international health activities relating to 

the prevention and control of infectious 

diseases; (8) advises the Director CCID 

and the Director, CDC, on policy matters 

concerning NCPDCID programs and 

activities; (9) coordinates development 

and review or regulatory documents and 

congressional reports; and (10) analyzes 

health programs and proposed 

legislation with respect to NCPDCID 

programs, goals and objectives. 

Dated: April 10, 2007. 

William H. Gimson, 

Chief Operating Officer, Centers for Disease 

Control and Prevention (CDC). 

[FR Doc. 07–1905 Filed 4–17–07; 8:45 am] 

BILLING CODE 4160–18–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. 2007N–0068] 

Medical Device User Fee and 

Modernization Act; Public Meeting 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of public meeting. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing a 

public meeting to discuss our proposed 

recommendations for the 

reauthorization of the Medical Device 

User Fee and Modernization Act of 2002 

(MDUFMA I) for fiscal years (FY) 2008 

through 2012, as well as other proposals 

to improve the review of medical 

devices and the third party inspection 

program. These proposed 

recommendations were developed after 

discussions with the regulated industry. 

Section 105 of MDUFMA I directs FDA 

to publish these proposed 

recommendations in the Federal 

Register, hold a meeting at which the 

public may present its views on the 

recommendations, and provide for a 

period of 30 days for the public to 

provide written comments on the 

recommendations. The public meeting 

and comment period will provide an 

opportunity for public input on the 

proposed recommendations from all 

interested parties, including the 

regulated industry, scientific and 

academic experts, healthcare 

professionals, and representatives of 

patient and consumer advocacy groups. 

DATES: The public meeting will be held 

on April 30, 2007, from 12 noon to 5 

p.m. Registration to attend and to 

present at the meeting must be received 

by April 25, 2007. (See section III.B of 

this document for details on 

registration.) Submit written comments 

by May 18, 2007. Transcripts will be 

available approximately 30 days after 

the meeting. (See section III.C of this 

document for more details on transcript 

availability.) 

ADDRESSES: The public meeting will be 

held at the Food and Drug 

Administration, 5630 Fishers Lane, rm. 

1066, Rockville, MD 20857. Submit 

written comments to the Division of 

Dockets Management (HFA–305), Food 

and Drug Administration, 5630 Fishers 

Lane, rm. 1061, Rockville, MD 20852. 

Submit electronic comments to http:// 

www.fda.gov/dockets/ecomments. All 

comments should be identified with the 

docket number found in brackets in the 

heading of this document. 

FOR FURTHER INFORMATION CONTACT: For 

information regarding this notice, 

contact: Erik Mettler, Office of Policy 

and Planning, Food and Drug 

Administration (HF–11), 5600 Fishers 

Lane, Rockville, MD 20857, 301–827–

3360, FAX: 301–594–6777, e-mail: 

Erik.Mettler@fda.hhs.gov. 

For information regarding 

registration, contact: Cynthia Garris, 

Office of Communication, Education, 

and Radiation Programs, Center for 

Devices and Radiological Health, Food 

and Drug Administration (HFZ–220), 

1350 Piccard Ave., Rockville, MD 

20850, phone: 240–276–3150 ext. 121, 

FAX: 240–276–3151; e-mail: 

cynthia.garris@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Introduction 

MDUFMA I (Public Law 107–250, 

October 26, 2002) amended the Federal 

Food, Drug, and Cosmetic Act (the act) 

to provide FDA with the following new 

responsibilities and resources: 

• User fees for premarket reviews of 

certain device premarket applications 

(see sections 737 and 738 of the act (21 

U.S.C. 379i and 379j)); 

• Performance goals to improve 

medical device reviews (see section 

101(3) of MDUFMA I and section 

738(g)(1) of the act); 

• Establishment inspections to be 

conducted by accredited third-parties 

when certain conditions are met (see 

section 704(g) of the act (21 U.S.C. 374)); 

and 

• Improved oversight and 

coordination of reviews of combination 

products (products that combine 

devices, drugs, or biologics) (see section 

503(g) of the act (21 U.S.C. 353(g))). 

A. Medical Device User Fees and 

Performance Goals 

In the years prior to MDUFMA I, 

FDA’s resources for our device and 

radiological health programs had 

increased at a lower rate than FDA’s 


pwalker on PROD1PC71 with NOTICES